Maternal morbidity and neonatal survival after periviable PPROM: the impact of latency duration
- 1Present Address: Department of Gynecology and Obstetrics, Istanbul Training And Research Hospital, Cerrahpaşa, General Abdurrahman Nafiz Gürman St. No:24, Istanbul, Fatih 34098 Türkiye
- 2Department of Obstetrics and Gynecology, Zeynep Kamil Women and Children’s Diseases Training and Research Hospital, Istanbul, Türkiye
Abstract
Background: Periviable preterm premature rupture of membranes (PPROM) is a rare (< 1%), critical obstetric complication associated with profound maternal and neonatal morbidity. Management involves a delicate trade-off between optimizing neonatal survival via pregnancy prolongation and mitigating maternal risks like chorioamnionitis, sepsis, and placental abruption. While expectant management is the standard to reach viability, research has predominantly focused on neonatal outcomes. Consequently, the potential for progressive, daily accumulation of maternal risk during latency remains insufficiently characterized. This study aims to identify maternal morbidity and risk factors, specifically evaluating the impact of latency duration on both safety and survival to provide objective data for clinical counseling and shared decision-making.
Methods: This retrospective cohort study analyzed 212 cases of PPROM diagnosed before 24 + 6 weeks’ gestation. Patients were classified by initial management into expectant management (n = 84) or termination of pregnancy (n = 128) groups. The primary outcome was composite maternal morbidity (CMM). To address confounding by indication, propensity-score matching was performed within the sub-23-week subcohort. Maternal complication accrual over the latency interval was evaluated using a competing-risks framework. Factors associated with neonatal survival to discharge were analyzed using Firth-penalized multivariable logistic regression to account for small-sample bias.
Results: In the propensity-score-matched cohort, expectant management was independently associated with a significant increase in CMM (matched OR 3.22; 95% CI 1.31–7.92; p = 0.011). Overall CMM rates were 32.1% in the expectant group and 11.7% in the termination group. Maternal temperature > 37 °C at admission was the strongest independent predictor of maternal morbidity across the entire cohort (OR 4.37; 95% CI 1.59–11.99; p = 0.005). Within the expectant management arm, each additional day of latency was not associated with a progressive increase in daily maternal risk (p = 0.299). Conversely, each day of pregnancy prolongation was significantly associated with an increased probability of neonatal survival to discharge (adjusted OR 1.058 per day; 95% CI 1.027–1.102; p < 0.001). Among live-born infants managed expectantly, the survival-to-discharge rate was 63.6%.
Conclusion: Expectant management of periviable PPROM is associated with a more than three-fold increase in maternal morbidity compared to termination; however, this risk does not escalate progressively with each additional day of latency. In contrast, every day of pregnancy prolongation significantly enhances the probability of neonatal survival to discharge. These findings indicate that in the absence of acute maternal complications and under vigilant clinical supervision, expectant management represents a rational and viable strategy to optimize neonatal outcomes without a compounding daily risk profile for the mother.
Supplementary Information: The online version contains supplementary material available at https://doi.org/10.1186/s12884-026-09759-x.
Related
- Survival of newborn and traditional practices of maternal and neonatal care- an analytical case-control study
- Trends in the Frequency of Severe Maternal Morbidity Among American Indian and Alaska Native Individuals at Two Major Hospitals in the East Valley, Arizona
- Preoperative CRP–Albumin–Lymphocyte (CALLY) Index Is Associated with Survival but Does Not Predict Anastomotic Leak or Major Morbidity After Minimally Invasive Esophagectomy
- Buccal DNA Methylation-Derived EpiScores are Associated with Neonatal Morbidity Burden in Infants born Very Preterm
- Exclusive Breastfeeding Duration, Infant Growth, and Infectious Morbidity in Term Infants: A Retrospective Cohort Study
BibTeX
@article{kolcu2026maternal,
title = {{Maternal morbidity and neonatal survival after periviable PPROM: the impact of latency duration}},
author = {Selma Atiye Kolcu and Habibe Ayvacı Taşan},
journal = {BMC Pregnancy and Childbirth},
year = {2026},
month = aug,
doi = {10.1186/s12884-026-09759-x},
url = {https://doi.org/10.1186/s12884-026-09759-x},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Maternal morbidity and neonatal survival after periviable PPROM: the impact of latency duration
AU - Selma Atiye Kolcu
AU - Habibe Ayvacı Taşan
PY - 2026
DA - 2026/08/07
JO - BMC Pregnancy and Childbirth
DO - 10.1186/s12884-026-09759-x
UR - https://doi.org/10.1186/s12884-026-09759-x
AB - Background: Periviable preterm premature rupture of membranes (PPROM) is a rare (< 1%), critical obstetric complication associated with profound maternal and neonatal morbidity. Management involves a delicate trade-off between optimizing neonatal survival via pregnancy prolongation and mitigating maternal risks like chorioamnionitis, sepsis, and placental abruption. While expectant management is the standard to reach viability, research has predominantly focused on neonatal outcomes. Consequently, the potential for progressive, daily accumulation of maternal risk during latency remains insufficiently characterized. This study aims to identify maternal morbidity and risk factors, specifically evaluating the impact of latency duration on both safety and survival to provide objective data for clinical counseling and shared decision-making. Methods: This retrospective cohort study analyzed 212 cases of PPROM diagnosed before 24 + 6 weeks’ gestation. Patients were classified by initial management into expectant management (n = 84) or termination of pregnancy (n = 128) groups. The primary outcome was composite maternal morbidity (CMM). To address confounding by indication, propensity-score matching was performed within the sub-23-week subcohort. Maternal complication accrual over the latency interval was evaluated using a competing-risks framework. Factors associated with neonatal survival to discharge were analyzed using Firth-penalized multivariable logistic regression to account for small-sample bias. Results: In the propensity-score-matched cohort, expectant management was independently associated with a significant increase in CMM (matched OR 3.22; 95% CI 1.31–7.92; p = 0.011). Overall CMM rates were 32.1% in the expectant group and 11.7% in the termination group. Maternal temperature > 37 °C at admission was the strongest independent predictor of maternal morbidity across the entire cohort (OR 4.37; 95% CI 1.59–11.99; p = 0.005). Within the expectant management arm, each additional day of latency was not associated with a progressive increase in daily maternal risk (p = 0.299). Conversely, each day of pregnancy prolongation was significantly associated with an increased probability of neonatal survival to discharge (adjusted OR 1.058 per day; 95% CI 1.027–1.102; p < 0.001). Among live-born infants managed expectantly, the survival-to-discharge rate was 63.6%. Conclusion: Expectant management of periviable PPROM is associated with a more than three-fold increase in maternal morbidity compared to termination; however, this risk does not escalate progressively with each additional day of latency. In contrast, every day of pregnancy prolongation significantly enhances the probability of neonatal survival to discharge. These findings indicate that in the absence of acute maternal complications and under vigilant clinical supervision, expectant management represents a rational and viable strategy to optimize neonatal outcomes without a compounding daily risk profile for the mother. Supplementary Information: The online version contains supplementary material available at https://doi.org/10.1186/s12884-026-09759-x.
SN - 1471-2393
ER -